Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-11-14 6:23 pm Unchanged | 2025-09-30 | 13G | CAMP4 Therapeutics Corporation CAMP | AH Bio Fund I, L.P. | 2,125,339 4.500% | 0 (Unchanged) | Filing History |
| 2025-11-14 4:49 pm Unchanged | 2025-09-30 | 13G | CAMP4 Therapeutics Corporation CAMP | Northpond Ventures II, LP | 2,238,244 4.800% | 0 (Unchanged) | Filing History |
| 2025-11-07 11:13 am Purchase | 2025-10-31 | 13G | CAMP4 Therapeutics Corporation CAMP | FMR LLC | 3,145,663 6.700% | 122,229 (+4.04%) | Filing History |
| 2025-10-07 3:49 pm Purchase | 2025-09-30 | 13G | CAMP4 Therapeutics Corporation CAMP | FMR LLC | 3,023,434 15.000% | 3,023,434 (New Position) | Filing History |
| 2025-10-01 11:30 am Unchanged | 2025-09-30 | 13G | CAMP4 Therapeutics Corporation CAMP | HarbourVest Partners LLC | 1,271,948 2.700% | 0 (Unchanged) | Filing History |
| 2025-09-17 6:31 pm Purchase | 2025-09-11 | 13G | CAMP4 Therapeutics Corporation CAMP | Vivo Opportunity Fund Holdings, L.P. | 3,561,793 7.600% | 3,561,793 (New Position) | Filing History |
| 2025-09-16 4:41 pm Purchase | 2025-09-10 | 13G | CAMP4 Therapeutics Corporation CAMP | Coastlands Capital LP | 4,886,722 10.000% | 4,886,722 (New Position) | Filing History |
| 2025-09-15 7:08 pm Unchanged | 2025-09-11 | 13D | CAMP4 Therapeutics Corporation CAMP | ENAVATE SCIENCES GP LLC | 3,785,802 8.100% | 0 (Unchanged) | Filing History |
| 2025-09-11 5:05 pm Purchase | 2025-09-09 | 13D | CAMP4 Therapeutics Corporation CAMP | Polaris Management Co. VII, L.L.C. | 3,932,251 8.400% | 1,307,189 (+49.80%) | Filing History |
| 2025-09-11 4:25 pm Purchase | 2025-09-09 | 13D | CAMP4 Therapeutics Corporation CAMP | 5AM Ventures VI L.P. | 5,869,091 12.500% | 2,941,176 (+100.45%) | Filing History |
| 2025-05-14 1:45 pm Purchase | 2024-12-31 | 13G | CAMP4 Therapeutics Corporation CAMP | HarbourVest Partners LLC | 1,271,948 6.300% | 1,271,948 (New Position) | Filing History |
| 2024-10-22 6:49 pm Purchase | 2024-10-15 | 13G | CAMP4 Therapeutics Corporation CAMP | Northpond Ventures II, LP | 2,238,244 11.500% | 2,238,244 (New Position) | Filing History |
| 2024-10-22 5:50 pm Purchase | 2024-10-15 | 13D | CAMP4 Therapeutics Corporation CAMP | Polaris Management Co. VII, L.L.C. | 2,625,062 13.500% | 2,625,062 (New Position) | Filing History |
| 2024-10-22 4:19 pm Purchase | 2024-10-15 | 13G | CAMP4 Therapeutics Corporation CAMP | AH Bio Fund I, L.P. | 2,125,339 10.900% | 2,125,339 (New Position) | Filing History |
| 2024-10-22 4:17 pm Purchase | 2024-10-15 | 13D | CAMP4 Therapeutics Corporation CAMP | 5AM Ventures VI L.P. | 2,927,915 15.000% | 2,927,915 (New Position) | Filing History |
| 2024-10-22 4:16 pm Purchase | 2024-10-15 | 13D | CAMP4 Therapeutics Corporation CAMP | ENAVATE SCIENCES GP LLC | 3,785,802 19.400% | 3,785,802 (New Position) | Filing History |